Search research articles
Contact Us
Filters
Showing results (271-280 of 381) with videos related to
Page
of 39
Sort By:
The Journal of Allergy and Clinical Immunology
|
April 1, 1985
Exercise-induced anaphylaxis: a serious form of physical allergy associated with mast cell degranulation
A L Sheffer, A K Tong, G F Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1987
The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes
R I Sperling, J L Robin, K A Kylander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 25, 2002
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy
O A Khan, A C Tselis, J A Kamholz, et al.
American Journal of Human Genetics
|
December 1, 1995
A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p
K L Anderson, L Baird, R A Lewis, et al.
The Journal of Biological Chemistry
|
February 25, 1984
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product
T H Lee, J M Menica-Huerta, C Shih, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 1987
Mapping X-linked ophthalmic diseases. III. Provisional assignment of the locus for blue cone monochromacy to Xq28
R A Lewis, J D Holcomb, W C Bromley, et al.
European Journal of Neurology
|
April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
O A Khan, A C Tselis, J A Kamholz, et al.
Journal of Medical Genetics
|
November 1, 1995
Gonadal mosaicism for incontinentia pigmenti in a healthy male
T T Kirchman, M L Levy, R A Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1981
Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis
L Levine, R A Morgan, R A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1984
An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells
E Razin, L C Romeo, S Krilis, et al.
Page
of 39
Search research articles
Search
Showing results (271-280 of 381) with videos related to
Sort By:
Page
of 39
The Journal of Allergy and Clinical Immunology
|
April 1, 1985
Exercise-induced anaphylaxis: a serious form of physical allergy associated with mast cell degranulation
A L Sheffer, A K Tong, G F Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1987
The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes
R I Sperling, J L Robin, K A Kylander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 25, 2002
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy
O A Khan, A C Tselis, J A Kamholz, et al.
American Journal of Human Genetics
|
December 1, 1995
A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p
K L Anderson, L Baird, R A Lewis, et al.
The Journal of Biological Chemistry
|
February 25, 1984
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product
T H Lee, J M Menica-Huerta, C Shih, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 1, 1987
Mapping X-linked ophthalmic diseases. III. Provisional assignment of the locus for blue cone monochromacy to Xq28
R A Lewis, J D Holcomb, W C Bromley, et al.
European Journal of Neurology
|
April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
O A Khan, A C Tselis, J A Kamholz, et al.
Journal of Medical Genetics
|
November 1, 1995
Gonadal mosaicism for incontinentia pigmenti in a healthy male
T T Kirchman, M L Levy, R A Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1981
Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis
L Levine, R A Morgan, R A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1984
An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells
E Razin, L C Romeo, S Krilis, et al.
Page
of 39